Ackermann Michael
SEC CIK 1791249 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Dir | 1.21M | $1.35M | $752.4K | 10 | 2021-08-05 | 2022-06-15 |
Most active insiders at TARS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| 2 | LINK WILLIAM J PHD | Dir | — | $4.48M |
| 3 | Whitfield Dianne C. | CHRO | — | $2.69M |
| 4 | Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| 5 | Neervannan Seshadri | COO | — | $2.00M |
| 6 | Farrow Jeffrey S | See Remarks | — | $1.32M |
| 7 | Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| 8 | Wahl Bryan | GC | — | $850.4K |
| 9 | Goodrich Katherine | Dir | — | $183.4K |
| 10 | Goldberg Andrew D. | Dir | — | — |
Ackermann Michael made no open-market trades at TARS in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-17 | 2022-06-15 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | M - OptEx | — | +4,257 | 1.21M | +0.4% | — |
| I | 2022-05-09 | 2022-05-05 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | P - Purchase | $13.50 | +100.0K | 100.0K | New | +$1.35M |
| M | 2021-12-03 | 2021-12-01 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $24.68 | -5,833 | 1.21M | -0.5% | -$143.9K |
| M | 2021-11-03 | 2021-11-01 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $27.82 | -5,833 | 1.21M | -0.5% | -$162.3K |
| M | 2021-10-14 | 2021-10-12 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $26.27 | -5,633 | 1.22M | -0.5% | -$148.0K |
| 2021-10-12 | 2021-10-08 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $25.03 | -200 | 1.22M | -0.0% | -$5,006 | |
| 2021-09-03 | 2021-09-01 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $25.24 | -5,833 | 1.22M | -0.5% | -$147.2K | |
| 2021-08-12 | 2021-08-11 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $25.15 | -621 | 1.23M | -0.1% | -$15.6K | |
| M | 2021-08-10 | 2021-08-06+ | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $25.00 | -3,829 | 1.23M | -0.3% | -$95.7K |
| M | 2021-08-06 | 2021-08-05 | TARS | Tarsus Pharmaceuticals, Inc. | Ackermann Michael | Dir | S - Sale | $25.00 | -1,383 | 1.23M | -0.1% | -$34.6K |
Purchase Sale Sale after option exercise All abbreviations